{"id":21219,"date":"2022-12-06T13:56:24","date_gmt":"2022-12-06T13:56:24","guid":{"rendered":"https:\/\/www.nottinghamtechventures.com\/?post_type=companies&p=21219"},"modified":"2022-12-21T16:11:16","modified_gmt":"2022-12-21T16:11:16","slug":"isomab","status":"publish","type":"companies","link":"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/","title":{"rendered":"IsomAb"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

IsomAb is a pre-clinical stage company with Proof-of-Concept data, in two animal models, and an ambitious plan to take its first product into the clinic by 2026.<\/p>\n","protected":false},"featured_media":21234,"template":"","meta":{"_acf_changed":false,"_links_to":"","_links_to_target":""},"sector":[150],"spin_out_name":[195],"acf":[],"yoast_head":"\nIsomAb - A spin-out from Nottingham Technology Ventures<\/title>\n<meta name=\"description\" content=\"IsomAb is a pre-clinical stage company with Proof-of-Concept data, in two animal models, and an ambitious plan to take its first product into the clinic by 2026.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IsomAb - A spin-out from Nottingham Technology Ventures\" \/>\n<meta property=\"og:description\" content=\"IsomAb is a pre-clinical stage company with Proof-of-Concept data, in two animal models, and an ambitious plan to take its first product into the clinic by 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/\" \/>\n<meta property=\"og:site_name\" content=\"Nottingham Technology Ventures\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-21T16:11:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.nottinghamtechventures.com\/wp-content\/uploads\/2022\/12\/Spin-outs-main-banners-and-news-featured-images-10-1024x683.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/\",\"url\":\"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/\",\"name\":\"IsomAb - A spin-out from Nottingham Technology Ventures\",\"isPartOf\":{\"@id\":\"https:\/\/www.nottinghamtechventures.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.nottinghamtechventures.com\/wp-content\/uploads\/2022\/12\/Spin-outs-main-banners-and-news-featured-images-10.png\",\"datePublished\":\"2022-12-06T13:56:24+00:00\",\"dateModified\":\"2022-12-21T16:11:16+00:00\",\"description\":\"IsomAb is a pre-clinical stage company with Proof-of-Concept data, in two animal models, and an ambitious plan to take its first product into the clinic by 2026.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/#primaryimage\",\"url\":\"https:\/\/www.nottinghamtechventures.com\/wp-content\/uploads\/2022\/12\/Spin-outs-main-banners-and-news-featured-images-10.png\",\"contentUrl\":\"https:\/\/www.nottinghamtechventures.com\/wp-content\/uploads\/2022\/12\/Spin-outs-main-banners-and-news-featured-images-10.png\",\"width\":2200,\"height\":1467},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.nottinghamtechventures.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IsomAb\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.nottinghamtechventures.com\/#website\",\"url\":\"https:\/\/www.nottinghamtechventures.com\/\",\"name\":\"Nottingham Technology Ventures\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.nottinghamtechventures.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.nottinghamtechventures.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.nottinghamtechventures.com\/#organization\",\"name\":\"Nottingham Technology Ventures\",\"url\":\"https:\/\/www.nottinghamtechventures.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.nottinghamtechventures.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.nottinghamtechventures.com\/wp-content\/uploads\/2018\/06\/ntv_graphics_r2_c4.png\",\"contentUrl\":\"https:\/\/www.nottinghamtechventures.com\/wp-content\/uploads\/2018\/06\/ntv_graphics_r2_c4.png\",\"width\":152,\"height\":74,\"caption\":\"Nottingham Technology Ventures\"},\"image\":{\"@id\":\"https:\/\/www.nottinghamtechventures.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IsomAb - A spin-out from Nottingham Technology Ventures","description":"IsomAb is a pre-clinical stage company with Proof-of-Concept data, in two animal models, and an ambitious plan to take its first product into the clinic by 2026.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/","og_locale":"en_GB","og_type":"article","og_title":"IsomAb - A spin-out from Nottingham Technology Ventures","og_description":"IsomAb is a pre-clinical stage company with Proof-of-Concept data, in two animal models, and an ambitious plan to take its first product into the clinic by 2026.","og_url":"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/","og_site_name":"Nottingham Technology Ventures","article_modified_time":"2022-12-21T16:11:16+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/www.nottinghamtechventures.com\/wp-content\/uploads\/2022\/12\/Spin-outs-main-banners-and-news-featured-images-10-1024x683.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/","url":"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/","name":"IsomAb - A spin-out from Nottingham Technology Ventures","isPartOf":{"@id":"https:\/\/www.nottinghamtechventures.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/#primaryimage"},"image":{"@id":"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/#primaryimage"},"thumbnailUrl":"https:\/\/www.nottinghamtechventures.com\/wp-content\/uploads\/2022\/12\/Spin-outs-main-banners-and-news-featured-images-10.png","datePublished":"2022-12-06T13:56:24+00:00","dateModified":"2022-12-21T16:11:16+00:00","description":"IsomAb is a pre-clinical stage company with Proof-of-Concept data, in two animal models, and an ambitious plan to take its first product into the clinic by 2026.","breadcrumb":{"@id":"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/#primaryimage","url":"https:\/\/www.nottinghamtechventures.com\/wp-content\/uploads\/2022\/12\/Spin-outs-main-banners-and-news-featured-images-10.png","contentUrl":"https:\/\/www.nottinghamtechventures.com\/wp-content\/uploads\/2022\/12\/Spin-outs-main-banners-and-news-featured-images-10.png","width":2200,"height":1467},{"@type":"BreadcrumbList","@id":"https:\/\/www.nottinghamtechventures.com\/companies\/isomab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.nottinghamtechventures.com\/"},{"@type":"ListItem","position":2,"name":"IsomAb"}]},{"@type":"WebSite","@id":"https:\/\/www.nottinghamtechventures.com\/#website","url":"https:\/\/www.nottinghamtechventures.com\/","name":"Nottingham Technology Ventures","description":"","publisher":{"@id":"https:\/\/www.nottinghamtechventures.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nottinghamtechventures.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.nottinghamtechventures.com\/#organization","name":"Nottingham Technology Ventures","url":"https:\/\/www.nottinghamtechventures.com\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.nottinghamtechventures.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.nottinghamtechventures.com\/wp-content\/uploads\/2018\/06\/ntv_graphics_r2_c4.png","contentUrl":"https:\/\/www.nottinghamtechventures.com\/wp-content\/uploads\/2018\/06\/ntv_graphics_r2_c4.png","width":152,"height":74,"caption":"Nottingham Technology Ventures"},"image":{"@id":"https:\/\/www.nottinghamtechventures.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.nottinghamtechventures.com\/wp-json\/wp\/v2\/companies\/21219"}],"collection":[{"href":"https:\/\/www.nottinghamtechventures.com\/wp-json\/wp\/v2\/companies"}],"about":[{"href":"https:\/\/www.nottinghamtechventures.com\/wp-json\/wp\/v2\/types\/companies"}],"version-history":[{"count":11,"href":"https:\/\/www.nottinghamtechventures.com\/wp-json\/wp\/v2\/companies\/21219\/revisions"}],"predecessor-version":[{"id":21280,"href":"https:\/\/www.nottinghamtechventures.com\/wp-json\/wp\/v2\/companies\/21219\/revisions\/21280"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nottinghamtechventures.com\/wp-json\/wp\/v2\/media\/21234"}],"wp:attachment":[{"href":"https:\/\/www.nottinghamtechventures.com\/wp-json\/wp\/v2\/media?parent=21219"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/www.nottinghamtechventures.com\/wp-json\/wp\/v2\/sector?post=21219"},{"taxonomy":"spin_out_name","embeddable":true,"href":"https:\/\/www.nottinghamtechventures.com\/wp-json\/wp\/v2\/spin_out_name?post=21219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}